Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
AYTU BioPharma
AYTU
$25.3M
| $217K | ﹤0.01% |
71,323
+2,400
| +3% | +$6.87K |
|
|
RGLS
3202
DELISTED
Regulus Therapeutics
RGLS
| $217K | ﹤0.01% |
75,500
+20,900
| +38% | +$34.1K |
|
3203
Lindblad Expeditions
LIND
$2.24B
| $216K | ﹤0.01% |
+23,200
| New | +$214K |
|
3204
Surrozen
SRZN
$284M
| $216K | ﹤0.01% |
13,726
+3,400
| +33% | +$38.1K |
|
3205
Anixa Biosciences
ANIX
$110M
| $215K | ﹤0.01% |
+68,800
| New | +$274K |
|
3206
Armata Pharmaceuticals
ARMP
$158M
| $215K | ﹤0.01% |
51,396
-2,200
| -4% | -$7.96K |
|
3207
Blue Ridge Bankshares
BRBS
$339M
| $215K | ﹤0.01% |
80,051
+38,551
| +93% | +$105K |
|
3208
iShares Global REIT ETF
REET
$5.08B
| $213K | ﹤0.01% |
+9,000
| New | +$211K |
|
|
SPRB
3209
Spruce Biosciences
SPRB
$135M
| $213K | ﹤0.01% |
3,613
+1,145
| +46% | +$291K |
|
3210
NB Bancorp
NBBK
$1B
| $212K | ﹤0.01% |
+15,500
| New | +$217K |
|
|
SYBX
3211
DELISTED
Synlogic
SYBX
| $212K | ﹤0.01% |
118,435
+63,805
| +117% | +$167K |
|
3212
Senseonics Holdings Inc
SENS
$419M
| $211K | ﹤0.01% |
19,830
-25,775
| -57% | -$299K |
|
3213
Outlook Therapeutics
OTLK
$166M
| $210K | ﹤0.01% |
17,600
+12,329
| +234% | +$99.7K |
|
|
WDH
3214
Waterdrop
WDH
$359M
| $210K | ﹤0.01% |
162,736
+136,536
| +521% | +$152K |
|
3215
authID Inc
AUID
$7.91M
| $209K | ﹤0.01% |
27,428
+7,800
| +40% | +$73.8K |
|
3216
Richmond Mutual Bancorp
RMBI
$257M
| $208K | ﹤0.01% |
18,742
+1,300
| +7% | +$14.8K |
|
3217
SB Financial Group
SBFG
$171M
| $208K | ﹤0.01% |
15,125
-118
| -0.8% | -$1.73K |
|
3218
Offerpad Solutions
OPAD
$22.5M
| $207K | ﹤0.01% |
2,555
-820
| -24% | -$71.9K |
|
|
VIRX
3219
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $207K | ﹤0.01% |
202,499
+23,600
| +13% | +$17.2K |
|
3220
Katapult Holdings
KPLT
$39.2M
| $206K | ﹤0.01% |
17,700
+2,796
| +19% | +$34.7K |
|
3221
MIND Technology
MIND
$42.6M
| $205K | ﹤0.01% |
44,940
-900
| -2% | -$5.27K |
|
3222
Schwab International Small-Cap Equity ETF
SCHC
$5.69B
| $204K | ﹤0.01% |
5,700
-4,023
| -41% | -$138K |
|
|
VIGL
3223
DELISTED
Vigil Neuroscience
VIGL
| $204K | ﹤0.01% |
+59,964
| New | +$187K |
|
3224
Key Tronic
KTCC
$42.8M
| $203K | ﹤0.01% |
43,600
+6,300
| +17% | +$28.7K |
|
|
DOMA
3225
DELISTED
Doma Holdings, Inc.
DOMA
| $203K | ﹤0.01% |
44,807
+1,400
| +3% | +$6.13K |
|
Similar funds
Jim Simons's Q1 2024 Portfolio in Review
As of Q1 2024, Jim Simons held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Chevron worth $331M.
- Jim Simons's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Jim Simons added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Jim Simons's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Jim Simons fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Jim Simons's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Jim Simons opened 562 new positions and closed 582 in Q1 2024.
- Jim Simons's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.